Every serving. No expiration date. Page 2 of 6.
Six hospitals changed everyday anesthesia practice, lowering estimated emissions and anesthetic spending without worsening tracked outcomes.
A brief tissue bridge moved helpful algae within three days—and recovery continued after the corals were separated.
NASA's newly launched space telescope has cleared an early commissioning test with more optical precision than its requirement demanded.
The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.
The first Afia Birago's puddle frogs ever born under human care are now hopping at London Zoo.
A new alliance is coordinating five years of targeted recovery funding.
Reported malaria deaths fell from 3,259 in 2011 to 52 in 2025.
An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.
A randomized trial found continuous glucose monitoring added about five hours a day in the target range—even without insulin.
Forty-four, from the brink.
Eight complete responses. Twelve patients.
The future changed 2.2 million times.
A 32-person study found less injury and fewer symptoms—but it is still early.
A monitor improved when patients could explain what its sensors got wrong.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.
A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.
More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.
The national average rose above one tonne per hectare in 2025–26; some farmer-field-school groups reached 1.4 to 2 tonnes while cutting pest treatments.
The 2026 count was the highest in Georgia’s statewide record. The long-run nesting trend has risen about 4% a year since the early 1990s.
Three mother-and-young pairs and two adolescent males passed health checks before being released into a protected 23,000-hectare forest.
The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.
A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.
WHO/Europe calls the result an early signal: the evaluation covers five months and independent peer review is pending.
The fund starts with $9 million from Walmart Foundation and $9 million in aligned investment from McDonald’s USA and suppliers.